丁型肝炎病毒稳定转染肝癌细胞系的建立
[Abstract]:Hepatitis D virus (hepatitis D virus,HDV) is a kind of virus-like ribonucleic acid (ribonucleic acid,RNA) virus, which requires hepatitis B virus (hepatitis B virus,HBV) to provide hepatitis B virus surface antigen (Hepatitis B virus surface antigen,HBsAg) for assembly, release and infection. Compared with HBV infection alone, HDV infection accelerates the degree of cirrhosis and increases the incidence of fulminant hepatitis and hepatocellular carcinoma. However, the current research on HDV is still relatively scarce, so it is necessary to strengthen the further study of HDV. At present, there are two ways to obtain hepatitis D virus: one is to extract HDV, directly from the serum of hepatitis D patients, but it is rare for patients with hepatitis D in China to rely on the direct extraction of HDV from the serum. The other is the HDV packaging method based on the transient transfection of plasmid into HuH-7 and other cell lines, but the workload will be increased when the research needs a large number of viruses, and the repeatability between the experimental batches is also poor. Xiamen University recently published a new method of HDV virus packaging based on adenovirus, which solves some problems. Up to now, however, there is no stable packaging cell line of HDV for mass production of HDV and evaluation of antiviral drugs. HDV is a satellite virus of HBV, which provides an alternative tool for the study of HBV infection. In this study, we constructed HDV replication packaging transposon vector and tried to transfect different hepatoma cell lines to verify the various HDV related replication and infection indexes. Finally, we screened out HDV monoclonal stable transfection cell lines with high packaging efficiency and high infectivity. In this study, the piggyBac (PB) transposon vector containing HDV replicon and HBsAg expression frame was constructed by molecular cloning and its function was evaluated. The constructed vector was transiently transfected into Hu H-7 cells. By detecting the content of HDV RNA and HBsAg in the supernatant, it was confirmed that the function of the vector was intact and the related functional genes were effectively expressed. The supernatant of HBV receptor sodium ion / taurocholate Cotransporting Polypeptide,NTCP (Na / taurocholate Cotransporting Polypeptide,NTCP) was confirmed to contain infectious HDV particles in the supernatant of the cells by the stable transfection of Na / taurocholate Cotransporting Polypeptide,NTCP. Several human hepatoma cell lines were transfected with this vector and other HDV replication and packaging vectors. A high packaging efficiency cell line K7 of HDV was obtained by rapid and large-scale screening of purine mycin. In this study, the content of HBV surface antigen in cell supernatant was detected by chemiluminescence assay. The level of HBV preS1 in supernatant was detected by Elisa, and the titer of HDV virus in supernatant was detected by quantitative PCR. The infection of supernatant HDV virus in vitro was evaluated by stably transfection of HBV receptor NTCP into HepG2.N9 cell line. The results showed that the replication and packaging of HDV were successfully established in this study. A large number of HBsAg and HBV preS1 were detected in the supernatant of the secreted human hepatoma cell line K7. The HDV titer of the supernatant of the cell reached 1 E 08GE/ml (GE,genome equivalents), which proved that the HDV virus secreted by the cell had a good infection in vitro. In this study, HDV expression vectors containing HDV replicon and HBsAg expression frame were constructed to screen human hepatoma cell lines from different sources. Finally, the monoclonal cell line K7, which has higher packaging efficiency and infectivity, was successfully screened out, which solved the problem of HDV packaging production on a large scale. It also provides a stable transfection cell model for screening potential hepatitis D molecular drugs in large scale.
【学位授予单位】:河北北方学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R373.21
【参考文献】
相关期刊论文 前10条
1 郑猛;;病毒性肝炎的预防及其疫苗应用[J];世界最新医学信息文摘;2016年30期
2 Celso Cunha;Jo?o Paulo Tavanez;Severin Gudima;;Hepatitis delta virus: A fascinating and neglected pathogen[J];World Journal of Virology;2015年04期
3 王融冰;;肝病的中医药治疗[J];临床肝胆病杂志;2015年01期
4 叶振东;;分析病毒性肝炎的中医治疗[J];中医临床研究;2014年17期
5 John M Taylor;;Host RNA circles and the origin of hepatitis delta virus[J];World Journal of Gastroenterology;2014年11期
6 吴志德;周沛林;;丁型肝炎病毒感染标志物在乙型肝炎病毒感染者中的检测研究[J];中华医院感染学杂志;2013年13期
7 许泼实;韩双印;孙长义;赵静;;乙型肝炎病毒感染者血清中丁型肝炎病毒标志物检测分析[J];中华实验和临床病毒学杂志;2012年04期
8 杨松;邢卉春;成军;;慢性丁型肝炎抗病毒治疗进展[J];中华实验和临床感染病杂志(电子版);2011年04期
9 邵惠训;;一种缺陷病毒——丁型肝炎病毒[J];首都公共卫生;2011年03期
10 卢学新;伊瑶;毕胜利;;丁型肝炎的分子生物学特征及研究进展[J];中华实验和临床病毒学杂志;2013年03期
,本文编号:2237411
本文链接:https://www.wllwen.com/yixuelunwen/jichuyixue/2237411.html